IP Library Granted Patent US 9,488,625
Granted Patent B2
US 9,488,625 · App. 13/325,778 · Granted Nov 8, 2016

Purification of factor VIII using a conductivity gradient

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,488,625
App. No.
13/325,778
Granted
Nov 8, 2016
Kind
B2
Abstract

The present specification discloses methods of eluting a protein from a chromatography column.

Claims (13)

1. A method of collecting an elution from a column, said method comprising the steps of:

a) applying a sample comprising a Factor VIII protein to a cation exchange chromatography column, wherein said Factor VIII protein is retained by said cation exchange chromatography column;

b) applying a mobile phase to said cation exchange chromatography column, said mobile phase comprising a buffered solution, wherein said mobile phase establishes a conductivity gradient of from about 4 mS/cm to about 90 mS/cm in said cation exchange chromatography column;

c) starting a single fraction eluate collection, wherein said single fraction eluate collection includes a single start conductivity value and a single stop conductivity value, wherein said single start conductivity value starts when an inlet conductivity value measured for said mobile phase of step b) enters said cation exchange chromatography column at about 25.0 mS/cm to about 27.0 mS/cm and when an outlet conductivity value measured for said mobile phase of step b) enters said cation exchange chromatography column at about 19.0 mS/cm to about 21.0 mS/cm; and

d) stopping said single faction eluate collection when said single stop conductivity value measured for said mobile phase of step b) at the inlet is from about 41.0 mS/cm to about 43.0 mS/cm and said single stop conductivity value measured for said mobile phase of step b) at the outlet is from about 34.5 mS/cm to about 36.5 mS/cm; and wherein said single fraction eluate collection comprises 83% Factor VIII protein activity retained by said cation exchange chromatography column in step a).

2. The method of claim 1 , wherein in step (b) said mobile phase establishes a conductivity gradient of from about 8 mS/cm to about 90 mS/cm.

3. The method of claim 1 , wherein said Factor VIII protein is a recombinant protein or a protein from an organism or a transgenic organism.

4. A method of collecting an elution from a column, the method comprising the steps of:

a) applying a sample comprising a Factor VIII protein to an anion exchange chromatography column, wherein said Factor VIII protein is retained by said anion exchange chromatography column;

b) applying a mobile phase to said anion exchange chromatography column, said mobile phase comprising a buffered solution, wherein said mobile phase establishes a conductivity gradient of from about 4 mS/cm to about 80 mS/cm in said anion exchange chromatography column;

c) starting a single fraction eluate collection, wherein said single fraction eluate collection includes a single start conductivity value and a single stop conductivity value, wherein said single start conductivity value starts when an inlet conductivity value measured for said mobile phase of step b) enters said anion exchange chromatography column at about 27.8 mS/cm to about 29.8 mS/cm and when an outlet conductivity value measured for said mobile phase of step b) enters said anion exchange chromatography column at about 21.0 mS/cm to about 23.0 mS/cm; and

d) stopping said single fraction eluate collection when said single stop conductivity value measured for said mobile phase of step b) at the inlet is from about 51.0 mS/cm to about 53.0 mS/cm and said single stop conductivity value measured for mobile phase of step b) at the outlet is from about 45.5 mS/cm to about 47.5 mS/cm; and wherein said single fraction eluate collection comprises 83% Factor VIII protein activity retained by said anion exchange chromatography column in step (a).

5. The method of claim 4 , wherein said Factor VIII protein is a recombinant protein or a protein from an organism or a transgenic organism.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036367/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036367/0357 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2012
From: FELGENHAUER, MARTIN; MAIERHOFER, HELMUT; MISON, DOMINIQUE; DESPONDS, ARNAUD
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 027990/0934 →